Merrimack Pharmaceuticals
MACK
#8760
Rank
โ‚ฌ0.20 B
Marketcap
13,79ย โ‚ฌ
Share price
0.00%
Change (1 day)
8.03%
Change (1 year)

Earnings for Merrimack Pharmaceuticals (MACK)

Earnings in 2024 (TTM): -โ‚ฌ2.09 Million

According to Merrimack Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ1.99 Million a decrease over its 2022 earnings that were of -โ‚ฌ1.99 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Merrimack Pharmaceuticals from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ2.09 Million5.19%
2023 -โ‚ฌ1.99 Million0.09%
2022 -โ‚ฌ1.99 Million-16.9%
2021 -โ‚ฌ2.39 Million-49.89%
2020 -โ‚ฌ4.76 Million-75.39%
2019 -โ‚ฌ19.34 Million-68.58%
2018 -โ‚ฌ61.52 Million-19.4%
2017 -โ‚ฌ76.33 Million-36.46%
2016 -โ‚ฌ0.13 Billion2.54%
2015 -โ‚ฌ0.12 Billion96.78%
2014 -โ‚ฌ59.54 Million-45.44%
2013 -โ‚ฌ0.11 Billion
2010 -โ‚ฌ42.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚ฌ7.09 B-344,855.64%๐Ÿ‡ซ๐Ÿ‡ท France
Geron
GERN
-โ‚ฌ17.35 Million 742.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
-โ‚ฌ0.2 Billion 9,523.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚ฌ26.47 Million 1,185.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ15.06 Million 631.30%๐Ÿ‡บ๐Ÿ‡ธ USA